While Medpace Holdings Inc has overperformed by 4.25%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MEDP fell by -19.50%, with highs and lows ranging from $459.77 to $250.05, whereas the simple moving average fell by -12.46% in the last 200 days.
On April 22, 2025, William Blair Downgraded Medpace Holdings Inc (NASDAQ: MEDP) to Mkt Perform. A report published by TD Cowen on April 14, 2025, Downgraded its rating to ‘Hold’ for MEDP. Leerink Partners also rated MEDP shares as ‘Market Perform’, setting a target price of $330 on the company’s shares in an initiating report dated March 24, 2025. Robert W. Baird October 23, 2024d the rating to Neutral on October 23, 2024, and set its price target from $413 to $349. Redburn Atlantic initiated its ‘Buy’ rating for MEDP, as published in its report on October 14, 2024. UBS’s report from September 27, 2024 suggests a price prediction of $350 for MEDP shares, giving the stock a ‘Neutral’ rating. Jefferies also rated the stock as ‘Hold’.
Analysis of Medpace Holdings Inc (MEDP)
Further, the quarter-over-quarter increase in sales is 9.30%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Medpace Holdings Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 65.82% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.73, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 485.85K can be a very valuable indicator of volatility for MEDP stock. On a monthly basis, the volatility of the stock is set at 5.77%, whereas on a weekly basis, it is put at 6.45%, with a gain of 2.15% over the past seven days. Furthermore, long-term investors anticipate a median target price of $307.89, showing growth from the present price of $302.88, which can serve as yet another indication of whether MEDP is worth investing in or should be passed over.
How Do You Analyze Medpace Holdings Inc Shares?
The USA based company Medpace Holdings Inc (MEDP) is one of the biggest names in Diagnostics & Research. When comparing Medpace Holdings Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 23.11, there is a growth in quarterly earnings of 14.63%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 19.01%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 90.04% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
MEDP shares are owned by institutional investors to the tune of 90.04% at present.
